SARS-Cov-2 Specific Antibody Responses in COVID-19 Patients
The rapid identification of the etiology and the sharing of the genetic sequence of the virus, followed by international collaborative efforts initiated due to the emergence of SARS-CoV-2 have led to the rapid availability of real-time PCR diagnostic assays that support the case ascertainment and tracking of the outbreak. More...30 Mar 2020
Abbott Launches New Test that Detects Coronavirus in Just Five Minutes
Abbott (Lake Forest, IL, USA) has been issued Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as five minutes and negative results in 13 minutes. The test will run on the company's ID NOW platform, providing rapid results in a wide range of healthcare settings such as physicians' offices, urgent care clinics and hospital emergency departments. More...28 Mar 2020
Rapid POC Screening Technology Uses Artificial Glycan Receptor to Detect Coronavirus in 20 Minutes
Iceni Diagnostics (Norwich, UK), a biotechnology company, is developing a new approach that identifies the virus not by its genetic code, which can mutate, but by using its reliance on chains of sugars which are constant and unchangeable. The existing prototype product for influenza can detect the virus in less than 20 minutes and could be adapted to identify other pathogens, such as the coronavirus. More...28 Mar 2020
New Rapid Coronavirus Test Gives Results in Just 15 Minutes
Sensitest International (Delfgauw, The Netherlands; www.sensitest.com), has developed a new coronavirus test that can show whether a patient has the IgM or IgG antibodies of the coronavirus (Covid-19) within 15 minutes. Sensitest’s Corona Rapid test for professional use is the only rapid test certified in the EU with a CE certificate issued by a European Notified Body. The product has been clinically tested with 596 patients, out of which 361 confirmed positive and 235 confirmed negative. More...28 Mar 2020
UC San Diego Partners with Diagnostics Manufacturers for COVID-19 Testing; Begins Trial to Assess Antiviral Drug
The UC San Diego Health and University of California San Diego School of Medicine (La Jolla, CA, USA) has announced that the UC San Diego Center for Advanced Laboratory Medicine (CALM), in a partnership with five leading in vitro diagnostics manufacturers, is significantly ramping up testing for COVID-19, projecting a capacity to complete 1,000 to 1,500 tests per day within two to three weeks. The five leading in vitro diagnostics manufacturers include Thermo Fisher Scientific (Waltham, MA, USA), Roche Diagnostics (Basel, Switzerland), GenMark Diagnostics (Carlsbad, CA, USA), Luminex Corporation (Austin, TX, USA) and Abbott Diagnostics (Lake Forest, IL, USA). More...28 Mar 2020
Randox and Bosch to Launch Game-Changing POC Coronavirus Test
Global diagnostics company Randox Laboratories (Crumlin, UK) and leading technology manufacturer Bosch Healthcare Solutions GmbH (Waiblingen, Germany) will launch a game-changing point of care coronavirus test in April 2020. The Vivalytic Viral Respiratory Tract Infection (VRI) Array can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. This provides a more comprehensive respiratory screening which enables precise and informed treatment decisions to be made. More...28 Mar 2020
Fulgent Partners with MedScan to Launch Next Generation Sequencing-Based Test for Coronavirus
Fulgent Genetics, Inc. (Temple City, CA, USA), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, has launched a NGS-based test for the coronavirus disease (COVID-19). Fulgent’s NGS test will be one of the market’s first diagnostic tests for the COVID-19 virus that has been developed based on NGS technology. Fulgent will partner with MedScan Laboratory (Williston, ND, USA) to launch the COVID-19 test and both have begun accepting specimens for testing from healthcare providers, clinics and reference labs. More...27 Mar 2020
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab
New
Chemistry Analyzer
MS100
In Other News
Abbott Launches Molecular Test for Novel Coronavirus (COVID-19)
GenMark Receives FDA Emergency Use Authorization for ePlex SARS-CoV-2 Test
Diazyme Announces Availability of COVID-19 Antibody Tests
BD, BioGX Submit EUA Request to FDA for New COVID-19 Diagnostics
Mesa Receives FDA EUA for 30 Minute POC Molecular COVID-19 Test
DiaSorin Receives BARDA Funding to Develop Rapid COVID-19 Test
LexaGene Accelerates FDA EUA Submission of Rapid, Onsite Analyzer for Detection of COVID-19
Hologic’s Panther Fusion SARS-CoV-2 Assay Receives FDA Emergency Use Authorization
bioMérieux Receives Emergency Use Authorization for BIOFIRE COVID-19 Test
Microbiologics Introduces First SARS-CoV-2 RNA IVD CE Marked Control
Quidel Receives FDA Emergency Use Authorization for Molecular COVID-19 Diagnostic Assay
Roche Receives Emergency Use FDA Approval for Automated Coronavirus Test
Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test
Israeli Researchers Introduce Pooling Method for COVID-19 Testing of Over 60 Patients Simultaneously
SARS-CoV-2 Detected in Multiple Sample Types
Promega Custom Manufacturing Capabilities Aid Rapid Development of New Coronavirus Test from Co-Diagnostics
Coronavirus Screening Test Developed by Johns Hopkins Microbiologists
Bio-Rad Launches SARS CoV-2 Standard for Coronavirus (COVID-19) Testing
AMSBIO Launches Recombinant Proteins and Antibodies for Detection of Coronavirus (COVID-19)
Novel Coronavirus Could Be Targeting Kidneys, Suggests New Data
Microbiologics Introduces SARS-CoV-2 Synthetic RNA for COVID-19 Research
Sentinel Diagnostics Develops Ready-To-Use Real-Time PCR Mix for Detection of Novel Coronavirus
Seegene Launches KFDA-Approved COVID-19 Assay
